Pharmaniaga's foray into Myanmar opens doors

KUALA LUMPUR: Pharmaniaga Bhd's successful foray into Myanmar with its Sinovac Covid-19 vaccine bodes well for its strategy to expand its vaccine distribution business beyond the local sector.

The pharmaceuticals group announced on Monday it had successfully exported the first batch of fill-finish Sinovac Covid-19 vaccines to Myanmar, manufactured by its wholly owned subsidiary Pharmaniaga Lifescience Sdn Bhd.